Therefore, our data suggest, that enabling c-MYC activation either through oncogenic K-Ras or B-Raf, or transcriptionally by deregulation of Wnt signalling is crucial in both, the serrated route as well as in the classical route to colorectal cancer [2]. Here, KRAS is linked to colorectal cancer.